Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

BACKGROUND: The 23-valent polysaccharide pneumococcal vaccine (PPV) is currently recommended in elderly and high-risk adults. However, its efficacy in preventing pneumococcal infections remains controversial. This study assessed the clinical effectiveness of vaccination against invasive pneumococcal...

Descripción completa

Detalles Bibliográficos
Autores principales: Vila-Corcoles, Angel, Ochoa-Gondar, Olga, Guzmán, Jorge A, Rodriguez-Blanco, Teresa, Salsench, Elisabet, Fuentes, Cruz M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848154/
https://www.ncbi.nlm.nih.gov/pubmed/20298596
http://dx.doi.org/10.1186/1471-2334-10-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848154/
https://www.ncbi.nlm.nih.gov/pubmed/20298596
http://dx.doi.org/10.1186/1471-2334-10-73

Ejemplares similares